Related Experiment Videos
Local erythematous dermatitis after intravenous docetaxel
Kouzo Hirai1, Osamu Ishiko, Satoko Nakajima
1Department of Obstetrics and Gynaecology, Osaka City University Medical School, Osaka, Japan. hiraik@med.osaka-cu.ac.jp
Gynecologic and Obstetric Investigation
|April 19, 2002
Summary
A patient experienced a localized skin rash after receiving docetaxel chemotherapy infusions. Histological examination confirmed the eruption as a mixed-type erythema multiforme.
Area of Science:
- Oncology
- Dermatology
- Pharmacology
Background:
- Docetaxel is a widely used chemotherapy agent for various cancers.
- Intravenous administration is a common route for docetaxel delivery.
- Skin reactions are potential adverse effects of chemotherapy.
Observation:
- A patient developed a localized skin eruption on the forearm.
- The eruption appeared proximal to the intravenous infusion site of docetaxel.
- Lesions emerged approximately one week post-infusion.
Findings:
- The skin eruption was characterized as erythema multiforme.
- Histological analysis confirmed a mixed-type presentation of erythema multiforme.
- The reaction was localized to the area of docetaxel administration.
Implications:
- This case highlights a specific cutaneous reaction to docetaxel.
- Understanding localized infusion site reactions is crucial for patient management.
- Further investigation into docetaxel-induced erythema multiforme may be warranted.